Bedaquiline Effect Towards QT Interval in Drug Resistant Tuberculosis (DR-TB): A Systematic Review
Objective: Bedaquiline is recommended by World Health Organization (WHO) to treat Drug-Resistant Tuberculosis (DR-TB). Bedaquiline is chosen due to its efficacy and safety in numerous studies. One adverse event that could happen is QT interval prolongation, which increases the risk of Torsade de Po...
Spremljeno u:
| Glavni autori: | , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Faculty of Medicine Siriraj Hospital
2023-09-01
|
| Serija: | Siriraj Medical Journal |
| Teme: | |
| Online pristup: | https://he02.tci-thaijo.org/index.php/sirirajmedj/article/view/263683 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|